FDA Adverse Event Injury Summary report: N

RX ACCULINK CAROTID STENT SYSTEM

MDR report key: 3171241 · Received June 14, 2013

Report

Report Number
2024168-2013-03760
Event Type
Injury
Date Received
June 14, 2013
Date of Event
September 25, 2012
Report Date
May 29, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040012
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECT OF HEADACHE IS A KNOWN OBSERVED AND POTENTIAL PATIENT EFFECT AS LISTED IN THE RX ACCULINK CAROTID STENT SYSTEM INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT POST RX ACCULINK STENT IMPLANTATION IN THE LEFT INTERNAL CAROTID ARTERY, THE PATIENT EXPERIENCED A HEADACHE AND BLURRED VISION THAT WERE TREATED WITH TYLENOL AND ULTRAM. ON (B)(6) 2012, THE HEADACHE RESOLVED AND THE PATIENT WAS DISCHARGED HOME. LATER IN THE DAY, THE PATIENT PRESENTED TO THE EMERGENCY ROOM STILL REPORTING THE BLURRED VISION AND WAS RE-ADMITTED TO THE HOSPITAL. ON (B)(6) 2012, THE BLURRED VISION RESOLVED AND THE PATIENT WAS DISCHARGED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
271829 RX ACCULINK CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT 2050761

Patients

Seq Age Sex Outcome Treatment
1 67 YR Hospitalization EMBOLIC PROTECTION: RX ACCUNET